CRWE Picks Announces Daily Tech Stock Watch - AQNM, NEPH

CRWEPicks.com tracks stocks daily and is pleased to offer its hot stock alerts. Investors can receive FREE Stock Alerts by visiting CRWEPicks.com at the following link: http://www.CRWEPicks.com.

Today's alerts include: Aquentium, Inc. (OTCBB: AQNM), and Nephros, Inc. (OTCBB: NEPH).

About Aquentium

Aquentium, Inc. (OTCBB: AQNM) is a diversified company with an emphasis on green technologies. The company manufactures non-chemical processing and sanitation equipment for the food, beverage, and hospitality industries. Their technology is designed to improve food and beverage safety standards both domestically and internationally.

Aquentium's ozone equipment is over 50% more effective than chemicals and over 3,000 times faster acting than chemicals. Aquentium believes they have better technology to combat e-coli, salmonella, listeria and other bacteria or viruses than what most processors are currently using.

Ozone is generated from Oxygen and is non-toxic.

The goal at Aquentium is to help prevent contamination of tomatoes, melons, leafy greens and any other food products. With the Aquentium non-chemical process, they can extend the shelf life of food product which means higher profits for processors and less waste for the consumer. With the Aquentium ozone equipment, a processor does not have to stop processing to do plant sanitation. This increases plant production. Ozone is also safer for the workers since there are no chemicals to handle. Ozone was approved by the FDA as food additive in 2001.

Aquentium, Inc., also recently announced that the company has secured 475 acres in the State of New Mexico for the development of an algae bio-fuel production facility.

Algae is uniquely suited to serve as the foundation for a new generation of renewable and low carbon transportation fuels. Algae is one of nature's most prolific and efficient photosynthetic organisms. Nearly all of algae's biomass is concentrated in the chloroplast, the engine that turns sunlight and CO2 into organic carbon, so that algae does not waste time or energy making stalks, roots, leaves, or fruits. This efficiency leads to very high yields of oil.

For example, while palm oil can yield 554 gallons of oil per acre, Aquentium believes their algae crop can yield over 10,000 gallons per acre; increasing oil output by a factor of twenty. Further, algae has a short growing cycle and does not require arable land or potable water. It can be grown quickly in brackish or salt water in the desert.

Aquentium's algae-based fuels will emit approximately two-thirds less CO2 than petroleum-based fuels at scale. When compared with conventional biofuels, such as corn ethanol and soy biodiesel, Aquentium's Green Crude has significantly less than half their carbon impact, while delivering far greater energy density than either alternative.

Algae-based fuels are one of the most promising technological developments to positively transform the world's transportation industry. Fuel from algae is an extremely logical approach to meet the needs for a green solution to our dependence on fossil fuels.

www.aquentium.com

About Nephros, Inc.

Nephros, Inc., headquartered in River Edge, New Jersey, is a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification.

The Nephros hemodiafiltration ("HDF") system is designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function.

The Nephros HDF system removes a range of harmful substances more effectively, and with greater capacity, than existing ESRD treatment methods, particularly with respect to substances known collectively as "middle molecules." These molecules have been found to contribute to such conditions as dialysis-related amyloidosis, carpal tunnel syndrome, degenerative bone disease and, ultimately, mortality in the ESRD patient. Nephros ESRD products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe.

The Nephros Dual Stage Ultrafilter (DSU) is the basis for the Nephros line of water filtration products. The patented dual stage cold sterilization ultrafilter has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites and biotoxins.

For more information about Nephros, please visit: http://www.nephros.com/.

About CRWEPICKS.COM

CRWEPicks.com is a stock watch website that provides free daily alerts on stocks. CRWEPicks.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. CRWEPicks.com also tracks small cap stocks that are on the brink of moving upwards. CRWEPicks.com also features companies on its website with research report, analysis, and newsletters.

CRWEPicks.com is an independent electronic publication that provides information on selected publicly traded companies. CRWEPicks.com is not a registered investment advisor or broker-dealer.

CRWEPicks.com and Crown Equity Holdings, Inc., affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

We encourage investors to join the FREE e-mail alerts by visiting:

http://www.CRWEPicks.com or sending an e-mail to info@CRWEPicks.com.

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our sites, stock alerts or joining our email list. CRWEPicks.com and Crown Equity Holdings, Inc. associates, consultants, employees are not registered as Investment Advisor or Broker Dealer in any jurisdiction whatsoever. Dr.StockPick.com is owned by Crown Equity Holdings. Full disclaimer can be read at http://www.CRWEPicks.com.

Release of Liability: Through use of our website, Email Alerts, and stock alerts viewing or using, you agree to hold Crown Equity Holdings, Inc., its operators, shareholders, consultants, associates and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. CRWEFinance and Crown Equity Holdings, Inc. affiliates and associates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Crown Equity Holdings, Inc. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and CRWEFinance makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Aquentium is paying 100,000 restricted shares to Crown Equity Holdings for media and public relations services.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statements. Therefore, you should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Kenneth Bosket

Crown Equity Holdings, Inc.

9663 Saint Claude Avenue

Las Vegas, NV 89148

USA

Phone: 702-448-1543

Fax: 702-258-9007

Note: The following news is from Crown Equity Holdings, Inc., and World Stock Wire, Inc. is not liable for the contents of this news.

Related terms: advisor, arable, biodiesel, broker, business, chemicals, clinical, contamination, contractors, corn, dealer, disease, email, e-mail, energy, equity, ethanol, europe, food, infection, investment, manufacturer, market, marketing, media, medical, new jersey, new mexico, note, oil, petroleum, plant, products, profit, public relations, research, securities, small cap, standards, technology, toxic, transportation, water, yield